Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-17-002333)

Filing Details

Accession Number:: 0001144204-17-002333
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-01-17 09:54:54
Reporting Period:: 2017-01-13

Filing Date:: 2017-01-17
Accepted Time:: 2017-01-17 09:54:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1385508	Opiant Pharmaceuticals Inc.	OPNT	Metal Mining (1000)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1553236	Kevin Pollack	C/O Opiant Pharmaceuticals, Inc. 401 Wilshire Blvd., 12Th Floor Santa Monica CA 90401	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-01-13	4,820	$6.98	4,820	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.26 to $7.05, inclusive.